Atlas Trials

Endostatin in Combination With Oxaliplatin and Radiotherapy in Esophageal Cancer Patients.

Clinical trial NCT02745561 · UNKNOWN

Trial details

NCT number
NCT02745561
Sponsor
Hangzhou Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Esophageal CancerEndostatin
Start date
2016-01-01
Primary completion
2017-12-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.